Tesamorelin

Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog studied in endocrine and metabolic research.

Used in research contexts to investigate GH/IGF-1 axis signaling, downstream metabolic markers, and body-composition endpoints under controlled protocols.

For research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease.

What's Included:

• 20mg lyophilized peptide

• Single-use research vial

• Lab-tested for purity and identity

• Certificate of Analysis included

Research Applications:

• Growth hormone (GH) axis research

• GHRH-receptor signaling studies

• Metabolic endocrinology investigations

• IGF-1 pathway research

• Body-composition endpoint studies in controlled models

FAQ:

• Q: Is Tesamorelin FDA-approved? A: Has FDA approval for specific clinical indications, but this is research-use-only.

• Q: Difference from CJC-1295? A: Tesamorelin is shorter-acting; CJC-1295 (with DAC) is longer-acting.